Articles
| Open Access |
DOI: Diagnostic And Prognostic Importance Of Proteinuria In Development Of Chronic Kidney Disease In Persons With High Risk Factor
Zhumaeva Madina Fakhriddinovna , Bukhara State Medical Institute, Bukhara, Uzbekistan Akhmedova Nilufar Sharipovna , Bukhara State Medical Institute, Bukhara, Uzbekistan Sulaimonova Gulnoza Tulkinzhanovna , Bukhara State Medical Institute, Bukhara, Uzbekistan Abdullaeva Umida Kurbanovna , Bukhara State Medical Institute, Bukhara, UzbekistanAbstract
Proteinuria, which is a predictor of early diagnosis of chronic kidney disease, is also a risk factor for the development and progression of renal pathology. The relationship is multifaceted and is built according to the type of feedback. On the one hand, the kidney can act as a target organ for most risk factors such as arterial hypertension, ischemic heart disease, diabetes mellitus, age, obesity associated with albuminuria. On the other hand, decreased renal function and severe albuminuria are an important reason for the accelerated development of end-stage chronic kidney disease.
Keywords
Proteinuria, albuminuria
References
Agranovich NV Justification and effectiveness of prevention and treatment of patients with chronic kidney disease in outpatient settings // Nephrology. St. Petersburg. 2013. Volume 17. No. 5, pages 43-48.
Vyalkova AA, Lebedeva EN et al. Clinical and pathogenetic aspects of kidney damage in obesity // Nephrology. St. Petersburg2014. Volume 18.No. 3, pages 24-33.
Nagaitseva S.S. Risk factors for increased albuminuria as an early marker of chronic kidney disease in different age groups // Nephrology. St. Petersburg. 2013 T. 17, No. 4. S. 58-62.
Nagaitseva S.S., Shvetsov M.Yu., Shalyagin Yu.D. Evaluation of albuminuria by test strips for the early detection of chronic kidney disease in individuals with different degrees of risk (experience of Health Centers of the Moscow Region) // Therapeutic Archives. Moscow. 2013. N26. S.38-43.
National recommendations. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches // Clinical Nephrology. Moscow. 2012. No. 4. S. 4-26.
Nephrology / ed. E. M. Shilova. //Moscow. GEOTAR-Media, 2007.S. 599-612
Nephrology: national guidelines / / ed. ON. Mukhina. Moscow. : GEOTAR-Media, 2009.720 p.
Smirnov A.V., Dobronravov V.A., Kayukov I.G. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches. National recommendations // Nephrology. St. Petersburg 2012. No. 1. S.89-115.
Imai E., Matsuo S., Makino H., Watanabe T. et al. Chronic Kidney Disease Japan Cohort (CKD-JAC) Study: Design and Methods // Hypertens Res. - 2008. - Vol.31, N6. - P. 1101-1107.
James MT, Hemmelgarn BR, Tonelli M: Early recognition and prevention of chronic kidney disease // Lancet 375.2010. Р 1296-1309
KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease // Kidney Int. USA / 2013. V.3, No.l. P.1-150.
Liam Manns, Nairne Scott-Douglas, 1 Marcello Tonelli, Robert Weaver, Helen Tam-Tham, and Brenda Hemmelgarn // A Population-Based Analysis of Quality Indicators in CKDClin J Am SocNephrol 12.2017. P 727-733
Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, HeJ: A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010 // Kidney Int 882015. P 950-957
Noordzij M, Leffondre K, vanStralen KJ, Zoccali C, DekkerFW, Jager KJ: When do we need competing risks methods for survival analysis in nephrology? // Nephrol Dial Transplant28 2013.P: 2670-2677
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization // N England J Med. 2004. No. 351. P. 1296-1305.
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.